Skip to main content
. 2020 May 29;2020(5):CD012947. doi: 10.1002/14651858.CD012947.pub2
Study identification First author, year of publication
Clinical features and settings Previous testing and clinical setting including country where the study was conducted. Presentation at recruitment, prior treatment that would affect the ACD (i.e. peripheral iridotomy, iridoplasty, etc.)
Participants Sample size, age, sex, ethnicity and country
Study design Whether the sample was selected as a single group (consecutive series) or as separate groups with and without the target condition (case‐control). Whether participants were consecutively enrolled in the study and were identified retrospectively or prospectively. Training involved for index tests, both eyes included in the study
Target condition An occludable angle as a referable condition, which includes PACS, PAC and PACG
Reference standard The reference standard test used: gonioscopy for diagnosing an occludable angle; this is acceptable if this is the only target condition in large‐scale screening or primary‐care settings. Gonioscopy combined with tonometry, visual fields investigation and optic disc assessment for distinguishing the relative subgroup of participants with an occludable angle as PACS/PAC/PACG
Index tests Oblique flashlight test: grade recorded
LACD using the van Herick technique: van Herick grade, or percentage, or both
SPAC: numerical or categorical grade, or both
Scheimpflug photography: ACA, ACV and ACD
AS‐OCT: model of OCT device, manufacturer and any technical characteristics (e.g. software analyses). TISA, ARA, AOD 500 microns and 750 microns for each parameter
Follow up Numbers of participants lost to follow‐up or who had uninterpretable test results
Notes Source of funding, anything else of relevance